Addus HomeCare (NASDAQ:ADUS) Given Overweight Rating at Stephens

Stephens reiterated their overweight rating on shares of Addus HomeCare (NASDAQ:ADUS) in a research note published on Tuesday, Benzinga reports. Stephens currently has a $115.00 price objective on the stock.

A number of other analysts have also weighed in on ADUS. William Blair restated an outperform rating on shares of Addus HomeCare in a research report on Monday, February 5th. Royal Bank of Canada reaffirmed an outperform rating and issued a $102.00 target price on shares of Addus HomeCare in a report on Thursday, February 29th. Barclays lowered Addus HomeCare from an equal weight rating to an underweight rating and set a $83.00 price target on the stock. in a research note on Tuesday, April 23rd. Bank of America raised their price objective on shares of Addus HomeCare from $115.00 to $118.00 and gave the company a buy rating in a report on Tuesday. Finally, Oppenheimer reissued an outperform rating and set a $118.00 target price on shares of Addus HomeCare in a report on Tuesday, March 26th. One analyst has rated the stock with a sell rating and eight have given a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of Moderate Buy and an average target price of $106.57.

Addus HomeCare Trading Up 6.8 %

Shares of ADUS stock opened at $104.59 on Tuesday. Addus HomeCare has a fifty-two week low of $78.35 and a fifty-two week high of $105.53. The stock’s fifty day moving average price is $98.73 and its two-hundred day moving average price is $92.61. The company has a debt-to-equity ratio of 0.18, a quick ratio of 1.38 and a current ratio of 1.38. The company has a market cap of $1.71 billion, a PE ratio of 27.24, a P/E/G ratio of 1.94 and a beta of 0.96.

Addus HomeCare (NASDAQ:ADUS) last released its quarterly earnings data on Monday, May 6th. The company reported $1.21 earnings per share for the quarter, beating the consensus estimate of $0.97 by $0.24. The business had revenue of $280.70 million for the quarter, compared to analyst estimates of $279.49 million. Addus HomeCare had a return on equity of 9.70% and a net margin of 5.91%. Addus HomeCare’s revenue was up 11.6% compared to the same quarter last year. During the same period last year, the firm posted $0.84 earnings per share. Equities analysts predict that Addus HomeCare will post 4.38 EPS for the current fiscal year.

Institutional Investors Weigh In On Addus HomeCare

Several institutional investors and hedge funds have recently made changes to their positions in ADUS. Exchange Traded Concepts LLC increased its stake in shares of Addus HomeCare by 0.8% in the 4th quarter. Exchange Traded Concepts LLC now owns 14,310 shares of the company’s stock valued at $1,329,000 after acquiring an additional 113 shares in the last quarter. Guinness Asset Management LTD grew its stake in shares of Addus HomeCare by 2.7% in the 3rd quarter. Guinness Asset Management LTD now owns 5,267 shares of the company’s stock valued at $449,000 after buying an additional 137 shares during the period. GAMMA Investing LLC increased its position in Addus HomeCare by 40.8% in the 1st quarter. GAMMA Investing LLC now owns 556 shares of the company’s stock valued at $57,000 after buying an additional 161 shares in the last quarter. Assetmark Inc. boosted its holdings in Addus HomeCare by 17.1% in the third quarter. Assetmark Inc. now owns 1,331 shares of the company’s stock worth $113,000 after acquiring an additional 194 shares in the last quarter. Finally, Inspire Investing LLC grew its stake in Addus HomeCare by 6.1% in the third quarter. Inspire Investing LLC now owns 3,600 shares of the company’s stock valued at $307,000 after acquiring an additional 207 shares during the period. Institutional investors own 95.35% of the company’s stock.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.